In this issue:
Antiviral regimens in HIV/HCV cirrhotic patients
Immediate vs deferred ART initiation
ART for perinatal HIV prevention
Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide single tablet
Vaccination of HIV-infected adults
CV risk management in people living with HIV
Time interval from HIV infection to viral suppression
Opioid substitution therapy and ART outcomes
Incidence and risk factors for Kaposi sarcoma
Statins for cirrhosis in HIV/HCV coinfection
Please login below to download this issue (PDF)